More than 20,000 hematologists, researchers and other medical professionals will attend the American Society of Hematology’s (ASH) Annual Meeting Dec. 3 to 6 in San Diego, Calif. to discuss diagnosis, treatment and prevention of leukemia, lymphoma, myeloma and other blood disorders. ASH is the world’s largest professional organization dedicated to hematology.
City of Hope experts can also comment on the following studies that will be part of the ASH Press Briefing on Saturday, Dec. 3:
Anthony S. Stein, M.D., director of the City of Hope Leukemia Program, co-director of the Gehr Family Center for Leukemia Research, and clinical professor of Hematology & Hematopoietic Cell Transplantation, can comment on a study on a novel therapy for acute myeloid leukemia. He is one of the study’s authors.
David S. Snyder, M.D., associate chair of City of Hope’s Department of Hematology & Hematopoietic Cell Transplantation and professor of hematology & hematopoietic cell transplantation, is a nationally-recognized expert in stem cell transplantation for treating leukemia and a variety of other blood disorders, notably myeloproliferative neoplasms. He can comment on a chronic myeloid leukemia study being presented at ASH.
The following City of Hope hematologists are available to speak about other research and treatment that will be discussed at ASH.
Lymphoma:Robert Chen, M.D.Assistant Professor in Department of Hematology & Hematopoietic Cell TransplantationTopics: Lymphoma, Hematology/Oncology & Hematopoietic Cell TransplantationChen is involved in clinical trials in all aspects of malignant hematology, including chemotherapy and stem cell transplantation protocols for blood cancers. Read about the results of his clinical trial on the targeted therapy brentuximab vedotin, which may cure some Hodgkin lymphoma patients whose disease has persisted despite receiving previous treatment.
Leslie L. Popplewell, M.D.Associate Clinical Professor, Department of Hematology & Hematopoietic Cell TransplantationHematologist/OncologistTopics: Lymphoma, Hematology/Oncology and Internal MedicineA clinician and professor at City of Hope’s Toni Stephenson Lymphoma Center, Popplewell is the principal investigator for a number of clinical trials examining new lymphoma therapies. She is also working on advanced transplant techniques for patients whose lymphoma has recurred.
Larry W. Kwak, M.D., Ph.D.Dr. Michael Friedman Professor in Translational Medicine, Director, Toni Stephenson Lymphoma Center and Associate Director for Developmental Therapeutics and Translational Research Topics: Lymphoma, Hematology & Hematopoietic Cell TransplantationKwak directs one of the biggest and most successful lymphoma treatment centers in the nation. He is a world-renowned physician and scientist who has pioneered breakthrough innovations in immunology and cancer vaccines. Myeloma:Amrita Krishnan, M.D.Director, Judy and Bernard Briskin Center for Multiple Myeloma ResearchTopics: Myeloma, Multiple Myeloma, Bone Marrow/Stem Cell TransplantationKrishnan was instrumental in bringing successful transplant therapy to HIV patients with lymphoma when many believed such patients were too weak to tolerate the procedure. She directs the multiple myeloma center, which seeks to make gains in one of the most rapidly changing areas in cancer research. Read a news release in which one of her myeloma studies is featured.
Leukemia:Steven T. Rosen, M.D.Provost and Chief Scientific Officer, Irell & Manella Cancer Center Director’s Distinguished Chair and Director, Beckman Research Institute of City of Hope Topic: Leukemia, Lymphoma, Multiple MyelomaRosen has built nationally recognized programs in laboratory sciences, clinical investigations, translational research and cancer prevention and control. He sets the scientific direction of City of Hope, shaping the research and educational vision for the biomedical research, treatment and education institution.
Anthony S. Stein, M.D.Chief, Director, Leukemia Program, Co-director, Gehr Family Center for Leukemia Research and Clinical Professor of Hematology & Hematopoietic Cell Transplantation Topics: Leukemia, Acute Myeloid Leukemia, Hematopoietic Cell TransplantationStein is principal investigator in multiple clinical trials examining the newest drugs for battling acute myeloid leukemia. Read a news release featuring his research presentation at ASH. If you would like to speak with any of our experts please call Letisia Marquez, senior media relations specialist, at 626-476-7593 or email at [email protected].
RSS